Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
Centering the conversation on what matters most.
View Issue
Sponsored and Supplied by Glaucoma Research Foundation
View Insert
Sponsored by Glaucoma Research Foundation
View Supplement
In This Issue
Arsham Sheybani, MD
What are the next steps for a patient with elevated IOP and glaucomatous damage who rejects topical therapy?
Steven R. Sarkisian Jr, MD; Dan Eisenberg, MD; Regine Pappas, MD; and Tony Realini, MD, MPH
The procedure may not benefit all patients with angle closure, but it plays an important role in some cases.
Alanna James, MD, and Benjamin Y. Xu, MD, PhD
A number of primary and secondary problems have been identified.
Zoya Veselovska (Veselovskaya), MD, DMSc; Natalia Veselovska (Veselovskaya), MD, DMSc; Orysia Bilyk; and Olga Piatiizbiantseva
Exploring the role of aqueous humor dynamics in the management of IOP.
Carol Toris, PhD, and Sayoko Moroi, MD, PhD
This conjunctiva-sparing procedure is relatively noninvasive, safe, and effective.
Abdelrahman M. Elhusseiny, MD, MSc; Mohamed M. Khodeiry, MD; Mohamed S. Sayed, MD; and Richard K. Lee, MD, PhD
A few of the many accounts of life-changing experiences with MIGS.With contributions from Arsham Sheybani, MD; Leonard K. Seibold, MD; and I. Paul Singh, MD
Reactions to an online petition show the potential impact of restricting access to MIGS care.
Current and future solutions may facilitate disease monitoring and management.
Yvonne Ou, MD
Patients with glaucoma deserve access to options that can help meet their goals.
Christine Larsen, MD
Surveys reflect uncertainty among patients and providers.With insights from Ciku Mathenge, MD, MSc, PhD, FEACO
Perspectives from a senior resident and an attending surgeon.
Jessie Wang, MD, and Mary Qiu, MD
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.
